# Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer

> **NCT01494415** · PHASE2 · UNKNOWN · sponsor: **First People's Hospital of Hangzhou** · enrollment: 21 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell

## Interventions

- **DRUG:** Paclitaxel for Injection（Albumin Bound）
- **DRUG:** carboplatin
- **RADIATION:** thoracic radiation therapy

## Key facts

- **NCT ID:** NCT01494415
- **Lead sponsor:** First People's Hospital of Hangzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07
- **Primary completion:** 2016-07
- **Final completion:** 2017-06
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2015-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01494415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01494415, "Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01494415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*